Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190015/S026

TREO Abdominal Stent-Graft System

Bolton Medical, Inc. · Decision date Mar 26, 2026

FDA DECISIONP190015/S026

What did the FDA approve?

FDA records P190015/S026 as a supplement to PMA P190015, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Mar 26, 2026.

FDA approval order statement

approval for the addition of 140mm contralateral length TREO Main Bifurcated Stent Graft size and modifications to the TREO B2/C2 delivery system
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Mar 26, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P190015/S026
Regulatory pathway
PMA supplement
Product code
MIH
Decision code
APPR
Decision date
Mar 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P190015/S025 · Related supplement

    TREO Abdominal Stent-Graft System

  2. P190015/S026 received

    Application receipt date recorded by FDA.

  3. P190015/S027 · Related supplement

    TREO Abdominal Stent-Graft System

  4. P190015/S029 · Related supplement

    TREO Abdominal Stent-Graft System

  5. P190015/S026 · FDA decision

    Normal 180 Day Track

  6. P190015/S024 · Related supplement

    TREO Abdominal Stent-Graft System

  7. P190015/S030 · Related supplement

    TREO Abdominal Stent-Graft System

Timeline entries are records held by MedtechLedger for P190015. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190015

Product / regulatory recordCompanyPathwayDecision dateSource
Bolton Medical, Inc.PMA supplementSep 3, 2025FDA
Bolton Medical, Inc.PMA supplementFeb 18, 2026FDA
Bolton Medical, Inc.PMA supplementFeb 19, 2026FDA
Bolton Medical, Inc.PMA supplementApr 13, 2026FDA
Bolton Medical, Inc.PMA supplementJun 18, 2026FDA

Explore the linked device profile

Other records with product code MIH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bolton Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
799 International Pkwy., Sunrise, FL, 33325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records